Join our community of smart investors

Life Science Reit trades on steep discount to NAV

Portfolio write-downs drive £13mn pre-tax loss
Life Science Reit trades on steep discount to NAVPublished on September 26, 2024
  • Leasing momentum improving 
  • Reit continues to trade at a steep discount to net asset value 

Almost three years following its IPO, things are starting to take off at Life Science Reit (LABS), which reported a 6.6 per cent increase in gross property income as leasing gathers momentum.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Already a subscriber? Sign in